Company
Korea (the Republic of)Byoung Chul Cho, M.D., Ph.D., Seodaemun, Korea (the Republic of) – FDA Inspections
Inspection records and compliance data for Byoung Chul Cho, M.D., Ph.D. in Seodaemun. 3 FDA inspections on record, last inspected February 02, 2024.
Company Profile
This profile covers Byoung Chul Cho, M.D., Ph.D. based in Seodaemun, Korea (the Republic of).
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected April 26, 2019. Last inspected February 2, 2024.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 2, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1230852 |
| May 13, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1172440 |
| April 26, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1092851 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Byoung Chul Cho, M.D., Ph.D.
FEI Number
3015176560
Address
Yonsei Univ. Hospital, Severance Cancer Center, 50-1 Yeonse-Ro, Seodaemun, Korea (the Republic of)
Country
Korea (the Republic of)
ID: fc87b816-061b-4330-8688-434a8f313f8d